ArticleCurrent cancer drug targets2026

Comprehensive Pan-cancer Analysis and Experimental Verification of EGLN Family: Potential Biomarkers in Cervical Cancer.

Dongli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.